National Health Investors, Inc. (NYSE:NHI) Receives Consensus Rating of “Moderate Buy” from Analysts

National Health Investors, Inc. (NYSE:NHI) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $83.8571.

Several equities research analysts have recently weighed in on NHI shares. Zacks Research downgraded National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Wells Fargo & Company decreased their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Finally, Truist Financial reduced their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday, June 12th.

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was acquired at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. The trade was a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company’s stock.

Hedge Funds Weigh In On National Health Investors

A number of hedge funds have recently bought and sold shares of NHI. NewEdge Advisors LLC grew its position in shares of National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of National Health Investors by 9.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after purchasing an additional 21,851 shares during the last quarter. Jane Street Group LLC lifted its stake in National Health Investors by 1,728.4% in the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after buying an additional 65,885 shares in the last quarter. Cetera Investment Advisers lifted its stake in National Health Investors by 6.1% in the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after buying an additional 275 shares in the last quarter. Finally, American Century Companies Inc. boosted its holdings in National Health Investors by 2.2% in the 2nd quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock worth $1,349,000 after buying an additional 420 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

Shares of National Health Investors stock opened at $80.49 on Monday. The company has a market capitalization of $3.90 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 3.62 and a beta of 0.51. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock’s 50-day simple moving average is $75.02 and its 200-day simple moving average is $79.74. National Health Investors has a 52 week low of $67.94 and a 52 week high of $91.38.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be issued a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. National Health Investors’s payout ratio is currently 118.71%.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.